Livzon Pharmaceutical repurchases A shares, H shares remain stable

Livzon Pharmaceutical Group Inc. submitted its Next Day Disclosure Return on September 19, 2025, detailing share movements for both its H shares and A shares. For its H ordinary shares, the company reported no changes, with the opening and closing balance as of September 19, 2025, remaining at 299,807,117 shares. There were no changes in treasury shares for H shares on this date.

In contrast, the company actively repurchased its A ordinary shares on the Shenzhen Stock Exchange, with a total of 127,200 A shares repurchased on September 19, 2025. These repurchases were executed at prices ranging from RMB 39.08 to RMB 39.63, with an aggregate price paid of RMB 4,998,667. These repurchased shares are currently held for cancellation, as indicated by the 127,200 shares designated for this purpose and zero shares for holding as treasury shares.

This latest repurchase activity on September 19, 2025, is part of a series of repurchases dating back to December 25, 2024, as detailed in the disclosure. The total number of issued A shares (excluding treasury shares) remained at 604,293,313 as of September 19, 2025, indicating that the repurchased shares have not yet been cancelled as of the closing balance date.